your everyday life
and Innovation
for Consumer
Our founding spirit of "contributing to people's health by producing good medicines" has been the most important belief that has driven Dong-A Pharmaceutical since 1932.
We will constantly strive to realize better health for our consumers.
- Establishment 1932
- Revenue in 2023 631B KRW
- No. of employees (2023) 1,012
- Operating Profit in 2023 (YoY 18.5%) 79.6B KRW
- Revenue CAGR (2021-2023) 20.1%
- Sales quantity of Bacchus (B bottles) 23.3
R&D Center
We explore various research areas
to assist our customers
in leading healthier lives.
-
Consumer-oriented InnovationConsumer-oriented InnovationWe aim for research
that challenges existing paradigms and resolves inconveniences. -
Material ResearchMaterial ResearchArmed with proven solutions,
we uncover new materials and incorporate them into our products. -
Formulation ResearchFormulation ResearchWe delve into formulation technologies that
effectively and safely deliver substances to the body. -
Analytical ScienceAnalytical ScienceAdapting swiftly to changing regulations and policies,
we continually enhance our analytical techniques to ensure top-notch quality. -
Sensory ScienceSensory ScienceOur research extends to solutions
that provide enjoyable and novel experiences through taste, smell, and touch. -
SustainabilitySustainabilityIn our pursuit of sustainable living,
we explore eco-friendly perspectives.
We work together our consumers on their journey toward a healthy life.
We work together our consumers on their journey toward a healthy life.
We will earnestly fulfill our corporate social responsibility, contributing to the creation of a brighter, warmer society.
Dong-A Socio Group's Jeong-Do management
redefines social responsibility, opting for "cauldron jeong (鼎)"
instead of the conventional "ethical jeong (正)"
to symbolize our group's unique founding spirit.
At Dong-A Socio Group, our management philosophy of "Jeong-Do management" embodies our commitment to "socially responsible management."